Biogen Inc · AM, Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. · PM, Join thousands of traders who. View today's Biogen Inc stock price and latest BIIB news and analysis. Create real-time notifications to follow any changes in the live stock price. Get Biogen Inc (BIIB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. NASDAQ: BIIB. $ Change. (%). Volume. 1,, 52 Week High. $ 52 Week Low. $ Sep 13, PM EDT. Image Stock Chart. Data. Biogen Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases.
What analysts recommend for BIIB stock, on a scale from 1(buy) to 5(sell). Buy. Strong. Biogen Inc. analyst estimates, including BIIB earnings per share estimates and analyst recommendations Stock Price Targets. High, $ Median, $ 17 minutes ago. Biogen Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Biogen (BIIB) Q2 Earnings & Sales Beat, Guidance Raised. Biogen (BIIB) beats second-quarter estimates for both earnings and sales. It raises EPS guidance. Get the latest Biogen Inc (BIIB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and. Stock Information. Stock Quote & Chart. Photo of vials. Breadcrumb. Home; Stock Information. NASDAQ: BIIB. $ Sep 12, PM EDT. Change. Find the latest Biogen Inc. (BIIB) stock quote, history, news and other vital information to help you with your stock trading and investing. Biogen Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. Biogen Inc. ; Volume, K ; Market Value, $B ; Shares Outstanding, M ; EPS (TTM), $ ; P/E Ratio (TTM), Biogen Inc.'s stock symbol is BIIB and currently trades under NASDAQ. It's current price per share is approximately $ What.
Find the latest historical data for Biogen Inc. Common Stock (BIIB) at ar-n.ru View historical data in a monthly, bi-annual, or yearly format. Biogen is a biotech company that develops, manufactures, and sells therapies for treating neurological and neurodegenerative diseases. See the latest Biogen stock price (NASDAQ: BIIB), related news, valuation, dividends and more to help you make your investing decisions. The latest Biogen stock prices, stock quotes, news, and BIIB history to help you invest and trade smarter. Discover real-time Biogen Inc. Common Stock (BIIB) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Research Biogen's (Nasdaq:BIIB) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. In the current month, BIIB has received 26 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. BIIB average Analyst price target in the past 3 months is $ We've gathered analysts' opinions on Biogen Inc. future price: according to them, BIIB price has a max estimate of USD and a min estimate of USD. View Biogen Inc. BIIB stock quote prices, financial information, real-time forecasts, and company news from CNN.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe. Biogen Inc BIIB:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date10/17/23 · 52 Week Low Get the latest Biogen Inc. (BIIB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Biogen Inc (BIIB) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Stock analysis for Biogen Inc (BIIB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
Discover real-time Biogen Inc. Common Stock (BIIB) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Find the latest historical data for Biogen Inc. Common Stock (BIIB) at ar-n.ru View historical data in a monthly, bi-annual, or yearly format. We've gathered analysts' opinions on Biogen Inc. future price: according to them, BIIB price has a max estimate of USD and a min estimate of USD. View today's Biogen Inc stock price and latest BIIB news and analysis. Create real-time notifications to follow any changes in the live stock price. Get Biogen Inc (BIIB.O) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investments. In the current month, BIIB has received 26 Buy Ratings, 9 Hold Ratings, and 0 Sell Ratings. BIIB average Analyst price target in the past 3 months is $ Complete Biogen Inc. stock information by Barron's. View real-time BIIB stock price and news, along with industry-best analysis. Biogen Inc BIIB:NASDAQ · Open · Day High · Day Low · Prev Close · 52 Week High · 52 Week High Date10/17/23 · 52 Week Low Biogen Inc stocks price quote with latest real-time prices, charts, financials, latest news, technical analysis and opinions. Biogen Inc · PM, Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools. · AM, Upgrade to FINVIZ*Elite to get. Stock Information. Stock Quote & Chart. Photo of vials. Breadcrumb. Home; Stock Information. NASDAQ: BIIB. $ Sep 13, PM EDT. Change. Biogen Share Price Live Today:Get the Live stock price of BIIB Inc., and quote, performance, latest news to help you with stock trading and investing. Biogen, Inc. is a biopharmaceutical company, which engages in discovering, developing, and delivering therapies for neurological and neurodegenerative diseases. The latest Biogen stock prices, stock quotes, news, and BIIB history to help you invest and trade smarter. Get the latest Biogen Inc (BIIB) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and. Biogen (BIIB) - Develops treatments for neurodegenerative, autoimmune and hematologic disorders. GROUP LEADERSHIP Medical-Biomed/Biotech Group. NASDAQ: BIIB. $ Change. + (+%). Volume. 87, 52 Week High. $ 52 Week Low. $ Sep 17, AM EDT. Image Stock Chart. Data. Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases in the United States, Europe. View Biogen Inc. BIIB stock quote prices, financial information, real-time forecasts, and company news from CNN. Biogen Inc (BIIB) stock price, GURU trades, performance, financial stability, valuations, and filing info from GuruFocus. Biogen Stock Declines % Year to Date: Time to Sell? BIIB's reasonable valuation, an improving pipeline and better sales prospects of new drugs are good. Research Biogen's (Nasdaq:BIIB) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more. Biogen Inc. · REAL TIME PM EDT 09/17/24 · USD · % · Volume, Get the latest Biogen Inc. (BIIB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. Stock analysis for Biogen Inc (BIIB:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile. See the latest Biogen stock price (NASDAQ: BIIB), related news, valuation, dividends and more to help you make your investing decisions. 51 minutes ago. 26 minutes ago.